Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pierre Kyme currently holds 9,461 shares of Armata Pharmaceuticals, Inc. (ARMP), valued at approximately $0. This represents their equity stake as Chief Business Officer.
Based on SEC Form 4 filings, Pierre Kyme has been a net neutral trader of ARMP stock. They have purchased $0 and sold $0 worth of shares.
Pierre Kyme's most recent insider trade was on Mar 14, 2026, when they sold 1,030 shares at $10.54 per share.
Pierre Kyme serves as Chief Business Officer at Armata Pharmaceuticals, Inc. (ARMP). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Pierre Kyme holds the position of Chief Business Officer at Armata Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Pierre Kyme has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Pierre Kyme was on Mar 14, 2026, when they sold $10.9K worth of ARMP shares. This transaction involved 1,030 shares at $10.54 per share.
Pierre Kyme currently owns 9,461 shares of Armata Pharmaceuticals, Inc. (ARMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pierre Kyme's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pierre Kyme has 2 Form 4 filings on record as an insider at Armata Pharmaceuticals, Inc..
Set alerts for Pierre Kyme and 40,000+ other insiders.